Skip to content

Analyses of the skin molecules in patients with Parkinson's disease(2)

Analyses of the skin molecules in patients with Parkinson's disease(2) - Analyses of the skin molecules in patients with Parkinson's disease(2)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000036115
Enrollment
50
Registered
2019-03-08
Start date
2019-03-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

1.Healthy adults 2.Parkinson&#39

Interventions

None listed

Sponsors

Kao Corporation
Lead Sponsor
Juntendo University
Collaborator

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: [The criteria for healthy subjects] 1.Healthy panelists who are 40-89 years old without Parkinson's disease. 2.Panelists who agree to have their typical daily routines. 3.Panelists who don't require assistance to participate in this trial. 4.Panelists who don't require the legally acceptable representatives. [The criteria for subjects with Parkinson's disease] 1.Panelists with sporadic Parkinson's disease (Hoehn & Yahr stage I or II). 2.Japanese male panelists who are 40-89 years old. 3.Panelists who agree to have their typical daily routines.

Exclusion criteria

Exclusion criteria: 1.Panelists who have the type I or II diabetes. 2.Panelists who have the malignant tumors. 3.Panelists who have the skin diseases, such as atopic dermatitis, acne vulgaris, and psoriasis vulgaris. 4.Panelists who have the infectious diseases, such as HIV, HCV, HIV, and syphilis. 5.Panelists who use the antibiotics within 2 weeks before participation in this study. 6.Panelists who use the prescription drugs having any effects to this study. 7.Panelists who use the prescription topical agents on the face 8.Panelists who is considered as inappropriate in this study.

Design outcomes

Primary

MeasureTime frame
The differences of skin molecules between healthy subjects and subjects with Parkinson's disease.

Secondary

MeasureTime frame
The differences of blood components between healthy subjects and subjects with Parkinson's disease. The relationship of the molecules between skin and blood.

Countries

Japan

Contacts

Public ContactYuya Uehara

Kao Corporation Biological Science Research

uehara.yuuya@kao.com+81-285-68-7461

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026